First Hawaiian Bank Alkermes Plc. Transaction History

First Hawaiian Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 08, 2024	BUY	$23.37 - $28.68 $273,078 - $335,125	11,685 New	11,685 $324,000
Q1 2019 Apr 02, 2019	SELL	$28.4 - $36.49 $15,620 - $20,069	-550 Closed	0 $0
Q4 2018 Jan 11, 2019	SELL	$27.94 - $44.61 $12,349 - $19,717	-442 Reduced 44.56%	550 $16,000
Q3 2018 Oct 16, 2018	BUY	$38.6 - $46.12 $38,291 - $45,751	992 New	992 $42,000

361

181M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.73B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of First Hawaiian Bank, based on Form 13F filings with the SEC.

Stay updated on First Hawaiian Bank with notifications on news.